Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bms-708163 + donepezil
- Development stage
- Unknown
- Lead developer
- Bristol Myers Squibb
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
BMS-708163 + donepezil is an experimental combination consisting of BMS-708163, a gamma-secretase inhibitor developed by Bristol Myers Squibb, and donepezil, an acetylcholinesterase inhibitor marketed as Aricept. BMS-708163 selectively blocks gamma-secretase–mediated amyloid precursor protein (APP) cleavage, inhibiting amyloid-beta peptide production implicated in Alzheimer’s disease, with reduced inhibition of the Notch pathway compared to earlier inhibitors[6]. Donepezil inhibits acetylcholinesterase, increasing acetylcholine levels to improve cognition and function in Alzheimer’s disease[5]. This combination was studied to assess pharmacokinetic interactions and safety in healthy subjects and Alzheimer’s patients.
- Brand names
- Aricept
- Other names
- BMS-708163BMS708163BMS 708163donepezilAricept
02
Targets
AcetylcholinesteraseGSEC (Gamma-Secretase Complex)
Beyond the preview
Go deeper on bms-708163 + donepezil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bms-708163 + donepezil.